Kiniksa Pharmaceuticals International Plc (KNSA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 12-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 0 | N/A | 0 | 0 | 56,075 |
| Other current assets | 0 | 0 | 0 | 0 | 259 |
| TOTAL | $0 | $N/A | $0 | $0 | $56,334 |
| Non-Current Assets | |||||
| PPE Net | N/A | N/A | N/A | N/A | 108 |
| Other Non-Current Assets | 0 | 0 | 0 | 0 | 40 |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $148 |
| Total Assets | $0 | $N/A | $0 | $0 | $56,467 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 0 | 0 | 0 | 0 | 210 |
| Accrued Expenses | 0 | N/A | 0 | 0 | 2,090 |
| TOTAL | $0 | $N/A | $0 | $0 | $2,302 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $0 | $N/A | $0 | $0 | $2,302 |
| Shareholders' Equity | |||||
| Common Shares | 0 | N/A | 0 | 0 | 1 |
| Retained earnings | 0 | N/A | 0 | 0 | -26,125 |
| Other shareholders' equity | 0 | 0 | 0 | 0 | 79,899 |
| TOTAL | $0 | $N/A | $0 | $0 | $54,165 |
| Total Liabilities And Equity | $0 | $0 | $0 | $0 | $56,467 |